Akhet Pharma

Haryana, India Founded: 2017 • Age: 9 yrs
Delivers comprehensive solutions for diabetes screening using anhydrous glucose.
Annual revenue $87,821 Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products - Services tracked
Competitors 10 Brand Intelligence

About Akhet Pharma

Akhet Pharma is a company based in India founded in 2017. It operates as a B2B. Akhet Pharma operates in a competitive market with competitors including Sana Biotechnology, Semma Therapeutics, Adocia, Rezolute and Cellino, among others.

  • Headquarter Haryana, India
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Legal Name Akhet Pharmaceuticals Private Limited
  • Date of Incorporation 21 Jun, 2016
  • Jurisdiction Jagadhri, Haryana, India
Operational Areas
Healthcare → Medical Devices & Diagnostics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $87.82 K (USD)
    84.21
    as on Mar 31, 2023
  • Net Profit
    $1.1 K (USD)
    -2.6
    as on Mar 31, 2023
  • EBITDA
    $7.45 K (USD)
    -8.32
    as on Mar 31, 2023
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Akhet Pharma

Premium access

Detailed funding history for Akhet Pharma

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Akhet Pharma

Investments
Premium access

Investment portfolio details for Akhet Pharma

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Akhet Pharma

Premium access

Detailed financials for Akhet Pharma

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Akhet Pharma Comparisons

Akhet Pharma Primary company
Description
Delivers comprehensive solutions for diabetes screening usin...
Location
India
Founded Year
2017
Annual Revenue
$87.82 K (USD)
Net Profit
$1.1 K (USD)
EBITDA
$7.45 K (USD)
Employees
Not available
Premium access

Peer comparison for Akhet Pharma

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Akhet Pharma

Akhet Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sana Biotechnology, Semma Therapeutics, Adocia, Rezolute and Cellino, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Genetically engineered cell therapies are developed for multiple disorders.
Locked Locked Locked
Provider of bio-artificial pancreas for Type 1 Diabetes treatment
Locked Locked Locked
Therapeutics for diabetes and obesity treatment are developed.
Locked Locked Locked
Therapies for metabolic and orphan diseases are developed by Rezolute.
Locked Locked Locked
Developer of autologous cell therapies
Locked Locked Locked
Pendulum is focused on developing advanced probiotic solutions.
Premium access

Detailed competitors of Akhet Pharma

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Akhet Pharma

Premium access

Complete news archive for Akhet Pharma

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Akhet Pharma

Akhet Pharma was founded in 2017.

Akhet Pharma is headquartered in India. It is registered at Haryana, India.

Annual revenue of Akhet Pharma is $87.82K as on Mar 31, 2023.

Akhet Pharma delivers comprehensive solutions for diabetes screening using anhydrous glucose through providing healthcare solutions, producing pharmaceutical products, diabetes care, and providing diagnostic solutions. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.

Akhet Pharma's top competitors include Sana Biotechnology, Semma Therapeutics and Adocia.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available